
A 2022 study exploring a vaccine design for pan-Sars-CoV-2 immunity was retracted last month after its lead author, then in Britain, admitted to fabricating data and falsifying images in the paper. While the retraction of the study, widely cited up until this year by international scientists, marks
Sunday, 22 November 2026
Connect your wallet to join the discussion.
No comments yet. Be the first to share your take.